TradeTrade
Jump to any asset 850 assets, updated daily

As of September 10, 2026, Intuitive Surgical Inc. (ISRG) trades at $358.08. CleaRank Financial AI rates it Buy with a fair value of $484.00, 35.2% above the current price. Wall Street's consensus target is $484.00 across 33 analysts. RSI at 24 is in oversold territory, and the price is below its 50-day average of $378.87.

Intuitive Surgical Inc. (ISRG)

Intuitive Surgical Inc. NASDAQ

$358.08 4.840 (1.37%)
Latest Price
AI Analyst Consensus
Buy
73 / 100
Intuitive Surgical Inc. (ISRG) is currently trading at $353.24, significantly below its 50-day and 200-day moving averages ($378.87 and $461.77), indicating a bearish technical trend. However, the company's fundamental outlook remains strong, supported by consistent revenue growth and a dominant market position in robotic surgery. Analysts maintain a predominantly Buy rating, with a median price target of $484.00, suggesting a 37% upside potential from current levels. The company's strong revenue growth, projected at 17.00% for the current year, underpins this optimistic outlook. The primary risk for ISRG lies in the heavy insider selling observed, with $139.3 million in sales in recent filings, signaling potential concerns among management. Despite this, the consensus rating remains Buy, reflecting confidence in the company's long-term growth prospects and market leadership. Investors should monitor future earnings reports and analyst updates closely, especially in light of the current oversold RSI reading.

ISRG Price Analysis

Market Metrics

Open
$348.24
Day Range
$345.35 to $358.82
Prev Close
$353.24
Volume
11.3K
52-Week Range
$328.57 to $603.88
Market Cap
$126.56B

Peer Benchmarking

Valuation vs Sector (Healthcare)

Performance vs XLV

Sector Position Analysis
Valuation is broadly in line with sector peers (-0.009118% difference), suggesting fair market pricing relative to industry standards.

ISRG Financial Performance

Revenue vs. Earnings

Annual

Quarterly

Earnings Reality Check

Analysis: In the last 5 quarters, ISRG beat estimates 5 times. However, the stock fell 3 times the next day. This suggests positive news is often "priced in" or investors are selling the news.

ISRG Analysis

Company's Health 4/5
12-Month Analyst Target +35.17% Upside
Median of 33 analysts (12-month)
$484.00
AI Technical Analysis Buy
Intuitive Surgical Inc. (ISRG) is currently trading below its 50-day and 200-day moving averages ($378.87 and $461.77), signaling a bearish trend. The Relative Strength Index (RSI) is at 23.57, indicating the stock is oversold and may be due for a potential bounce. MACD is also negative, further reinforcing the bearish momentum. Key support levels are not clearly defined due to the current downtrend, but the oversold RSI suggests that significant downside may be limited in the short term. Volume has been above average recently, which could indicate increased investor interest, though the price action remains weak. The current technical setup suggests caution, but the oversold condition presents a potential entry point for long-term investors.
ProTips
  • Monitor insider transaction activity closely; a reversal from net selling to net buying could signal renewed management confidence.
  • The current oversold RSI reading (23.57) suggests a potential short-term buying opportunity, but confirmation from price action and volume is advised.
  • Given the significant insider selling, consider a more conservative position sizing until a clear bullish trend emerges.
Key Catalysts
Bearish Heavy Insider Selling Continues

Insiders have sold $139.3 million worth of ISRG stock across 138 transactions, indicating potential concerns about future performance or valuation among management.

Source: Insider Trading Data
Bullish Oversold RSI Suggests Potential Reversal

The Relative Strength Index (RSI) is at 23.57, indicating the stock is in oversold territory and may be due for a technical bounce or short-term recovery.

Source: Technical Analysis
Bullish Strong Analyst Conviction and Upside Potential

The median analyst price target of $484.00 suggests a 37% upside from the current price, with a majority of analysts maintaining Buy or Outperform ratings.

Source: Wall Street Analysts
Bullish Consistent Revenue Growth

Intuitive Surgical Inc. reported 18.5% year-over-year revenue growth, with projections for 17.00% growth in the current year, demonstrating sustained business expansion.

Source: Company Financials
Market Outlook
The base case scenario for Intuitive Surgical Inc. (ISRG) anticipates a recovery towards its median analyst target price of $484.00 within the next 6-12 months, driven by its strong market position and consistent revenue growth. The current oversold RSI suggests potential for a near-term rebound, which could be the catalyst for this recovery. The company's projected revenue growth of 17.00% for the current year and 13.00% for the next year provides a solid foundation for this outlook. Potential upside catalysts include a shift in insider sentiment, a successful integration of new technologies, or stronger-than-expected market adoption of its robotic surgery systems. Conversely, sustained heavy insider selling, increased competition, or regulatory hurdles could pressure the stock lower, potentially testing the downside projection of $234.06 from the Monte Carlo simulation.

Key Statistics

Market Cap 126.56B
P/E Ratio 40.03
EPS (TTM) 8.73
Dividend Yield 0.00%
52 Week High 603.88
52 Week Low 328.57
Intuitive Surgical Inc. (ISRG) exhibits a P/E ratio of 40.03, which is in line with its sector average, suggesting fair valuation relative to its peers in the medical instruments and supplies industry. The company's revenue growth has been strong, with an 18.5% year-over-year increase reported, and is projected to grow by 17.00% in the current year. This growth is supported by strong forward revenue estimates, with next year's sales expected to increase by 13.00%. While the valuation appears reasonable within its sector, the significant insider selling, totaling $139.3 million, warrants attention. This activity contrasts with the positive analyst sentiment and forward growth projections. Investors should weigh the company's strong market position and growth trajectory against the insider selling signal when considering an investment.

Earnings & Growth Analysis

Intuitive Surgical Inc. (ISRG) recently reported an EPS of $2.80 for its latest quarter, surpassing the analyst estimate of $2.50 by 12%. This follows a pattern of consistent earnings beats, including an 18.48% surprise in the prior quarter. The stock experienced a 14.15% price decline following the most recent earnings report, despite the EPS beat, highlighting potential investor concerns or broader market sentiment impacting the stock.

Key Risks

The most significant risk for Intuitive Surgical Inc. (ISRG) is the heavy insider selling, with $139.3 million in dispositions, which could signal a lack of confidence from management. Additionally, the stock is trading significantly below its key moving averages, indicating a bearish technical trend that could persist. Competitive pressures within the robotic surgery market, though currently managed well, remain a long-term consideration.

Technical Indicators i

RSI (14) 23.57
MACD -6.01
SMA 50 378.87
SMA 200 461.77
Technical Rating Bearish
RSI
Oversold
SMA Cross
Bearish
Price vs SMA
Bearish
MACD
Bearish
Moving averages show a lagging Death Cross (50-day: $378.87, 200-day: $461.77), price is trading below the 50-day SMA, RSI at 23.6 suggests oversold conditions; potential bounce setup.

Market Correlations

How this stock moves relative to other assets

Based on 1 year of daily price data. Correlations may vary over different time periods.

S&P 500 (SPY) +0.53
Moderate correlation
Nasdaq 100 (QQQ) +0.47
Moderate correlation
Bitcoin (BTC) -0.10
Weak correlation
Gold (XAU) +0.07
Weak correlation
Check Custom Correlation

ISRG Trade Plans

Specific entry, exit, and risk management levels

Select Your Trade Bias
Risk Tolerance
Conservative 2% Aggressive
Portfolio Value
$
Position Size: Enter portfolio size →

🟢 LONG ENTRY (click to switch)

CONSERVATIVE
$350.92
2% below current price (Pullback entry)
Lower risk, wait for pullback
AGGRESSIVE
$358.08
Buy at current price
Higher risk, immediate entry

Risk Management

STOP LOSS
$328.32
MAX LOSS
-6.4%
Volatility-Adjusted Stop Loss
Calculated based on RSI (23.6) and current market volatility

Profit Targets (Based on Conservative Entry)

TARGET 1
$368.46
+5% (Conservative)
+2.9% (Aggressive)
TARGET 2
$386.01
+10% (Conservative)
+7.8% (Aggressive)
TARGET 3
$403.56
+15% (Conservative)
+12.7% (Aggressive)
Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3
ℹ️ Disclaimer
This AI-generated trade plan for ISRG is for educational and informational purposes only and does not constitute financial advice. The analysis is based on historical data patterns and technical indicators which may not predict future results. Stock trading involves risk of loss. Verify all data independently and consult a qualified financial advisor. Generated on September 11, 2026.

Growth of $10,000

A $10,000 investment in ISRG in September 2016 would be worth about $46,520 today, compared with about $35,241 for the same investment in the S&P 500 benchmark.

Compare with Another Ticker

Monte Carlo Projection (10yr)

CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in ISRG today could grow to about $29,888 by 2036 in the base case, with a bull case near $114,512 and a bear case around $7,801. Projections are statistical simulations, not guarantees.

ISRG Stock Price Prediction: 2030

CleaRank's simulation projects a price near $555 for ISRG by 2030 in the base case, from $358 today (1.5x over 4 years). The downside path ends near $237. These are outcomes of a Monte Carlo simulation run on ISRG's historical return distribution, not price targets, and they assume no dividends are reinvested.

ISRG simulated price paths by year
Year Downside (10th pct) Base case Upside (90th pct)
2027 $261 $400 $611
2028 $244 $446 $813
2029 $238 $497 $1,038
2030 $237 $555 $1,298
2031 $239 $619 $1,600
2032 $244 $691 $1,955
2033 $250 $771 $2,371
2034 $259 $860 $2,859
2035 $268 $959 $3,430
2036 $279 $1,070 $4,100

Method: 10,000 simulated price paths using ISRG's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice.

People Also Watch

ISRG Insider Trading Analysis

Source: SEC Form 4
Bought
None
No open-market buys
Sold
$139.3M
57 Transactions
Insiders
23
Active Traders
$ Avg Transaction
$2.4M
Large trades
Recent insider transactions in ISRG
Date Insider Type Shares Value
Feb 28, 2024
MOHR MARSHALL L
Officer
Sell 108.8K $41.9M
Feb 7, 2024
ROSA DAVID J
President
Sell 80.7K $31.4M
Apr 24, 2023
ROSA DAVID J
Officer
Sell 81.6K $24.4M
Aug 23, 2024
CHARLTON HENRY L
Officer
Sell 40.2K $19.6M
Apr 26, 2021
MOHR MARSHALL L
Chief Financial Officer
Sell 22.0K $19.0M
Jul 31, 2023
GUTHART GARY S
Chief Executive Officer
Sell 55.3K $18.1M
Oct 24, 2025
GUTHART GARY S
Officer and Director
Sell 31.6K $17.3M
Jul 26, 2022
GUTHART GARY S
Chief Executive Officer
Sell 79.4K $17.2M
Feb 14, 2020
SMITH LONNIE M
Director
Sell 28.2K $16.9M
Aug 6, 2021
ROSA DAVID J
Officer
Sell 16.2K $16.4M

Frequently Asked Questions

Is Intuitive Surgical Inc. (ISRG) stock a buy right now?
Intuitive Surgical Inc. (ISRG) is currently rated as a Buy by Wall Street analysts, with a median price target of $484.00, suggesting a 37% upside from its current price of $353.24. The stock's RSI is oversold, which could indicate a potential near-term bounce, but significant insider selling presents a notable risk.
What is ISRG's stock price forecast for 2030?
Based on Monte Carlo simulations, Intuitive Surgical Inc. (ISRG) has a projected base case price of $547.35 by 2030, with a downside projection of $234.06 and an upside projection of $1280.01. These are statistical outcomes, not guarantees.
What are the biggest risks facing Intuitive Surgical Inc. (ISRG)?
The primary risks for ISRG include significant insider selling totaling $139.3 million, a bearish technical trend with the stock trading below key moving averages, and potential competitive pressures in the robotic surgery market.
How does ISRG's valuation compare to its sector averages?
Intuitive Surgical Inc. (ISRG) has a P/E ratio of 40.03, which is in line with the sector average of 40.03. Its revenue growth of 18.5% is strong compared to the sector average of 10.00%.
What is the Wall Street consensus for ISRG stock?
The Wall Street consensus for ISRG is predominantly Buy, with 33 analysts covering the stock. The consensus score is 73 out of 100, with 7 Strong Buys, 17 Buys, and 8 Holds.
Has Intuitive Surgical Inc. (ISRG) met its recent earnings expectations?
Yes, Intuitive Surgical Inc. (ISRG) has consistently beaten analyst EPS estimates in recent quarters, including a 12% surprise in its latest report. However, the stock price declined following the most recent earnings release.
What is the dividend yield for ISRG stock?
Intuitive Surgical Inc. (ISRG) does not currently pay a dividend, with a dividend rate and yield of 0%.

Disclaimer: CleaRank.com is a financial data and analytics provider, not a registered investment advisor, broker-dealer, or financial regulatory body. The stock analysis, trade plans, and AI-generated signals presented for ISRG are for educational and informational purposes only and do not constitute financial advice, investment recommendations, or an offer to buy or sell any securities. All trade setups and performance metrics shown are hypothetical, hindsight-based, and simulated. They do not represent actual trades made by CleaRank or its affiliates. Stock prices can be volatile and are subject to market, economic, and company-specific risks. Market data is provided "as-is" and may be delayed by 15 minutes or more. We do not guarantee the accuracy, completeness, or timeliness of any data. You should never invest money you cannot afford to lose. Past performance does not guarantee future results. Consult a qualified financial advisor before making any investment decisions. Analysis generated on September 11, 2026.